| |
 |
 |
| Company Name |
Novartis (Taiwan) Co., Ltd. |
| Protocol Number |
CICL670ATW02 |
| Title of Study |
A non-interventional, multi-center, surveillance study to observe long-term safety of Exjade® in patients with myelodysplastic syndrome (MDS), aplastic anemia (AA) and other rare anemia patients at risk for chronic transfusional related iron overload |
| Primary Objective |
To collect long-term safety data on treatment with Exjade®, iron chelator, in MDS, AA and other rare anemia patients with transfusional hemosiderosis for 3 years under conditions of general clinical practice |
| Number of Sites |
11 |
| Period of Study |
from 2009-08-21 to 2013-08-31 |
| Number of Patients |
100 |
| IRB Approval Date |
25-Jun-2009 |
| Publication Plan / Date |
30-May-2014 |
|
|
|
|
